Article Figures & Data
Tables
PET/CT result and outcome IMRT + cisplatin IMRT Total PET overall interpretation Positive for residual tumor 0 (0.0%) 2 (3.4%) 2 (1.7%) Negative for residual tumor 57 (100.0%) 56 (96.6%) 113 (98.3%) 2-y PFS status in PET-negative Failure 4 (7.0%) 5 (8.9%) 9 (8.0%) Nonfailure 53 (93.0%) 51 (91.1%) 104 (92.0%) NPV of 2-y PFS 93.0% 91.1% 92.0% 95% exact CI 83.0%–98.1% 80.4%–97.0% 85.4%–96.3% One-sided 90% exact LCB 86.5% 84.1% 87.7% H0: NPV ≤ 90% vs. HA: NPV > 90% P value (exact) 0.2964 PET/CT result and outcome IMRT + cisplatin IMRT Total PET overall interpretation Positive for residual tumor 0 (0.0%) 2 (3.6%) 2 (1.8%) Negative for residual tumor 56 (100.0%) 54 (96.4%) 110 (98.2%) 2-y LRC status in PET-negative Failure 3 (5.4%) 3 (5.6%) 6 (5.5%) Nonfailure 53 (94.6%) 51 (94.4%) 104 (94.5%) NPV of 2-y LRC 94.6% 94.4% 94.5% 95% exact CI 85.1%–98.9% 84.6%–98.8% 88.5%–98.0% One-sided 90% exact LCB 88.5% 88.0% 90.6% H0: NPV ≤ 90% vs HA: NPV > 90% P value (exact) 0.0682
Supplemental Data
Files in this Data Supplement: